FDA: Osteoporosis Drug Prolia May Be Linked To Hypocalcemia In Kidney Patients
SILVER SPRING, Md. — The Food and Drug Administration has issued a drug safety communication that it is investigating the risk of severe hypocalcemia with serious outcomes including hospitalization and death...To view the full article, register now.
Already a subscriber? Click here to view full article